Capital expenditure guidance points to faster build-out of AI training, Optimus robotics and Cybercab production, while ...
Detailed price information for Biomea Fusion Inc (BMEA-Q) from The Globe and Mail including charting and trades.
Colt Keith’s production through the first month of the 2026 season is supported by measurable changes in contact quality, ...
Q1 2026 Earnings Call April 30, 2026 4:30 PM EDTCompany ParticipantsJoshua Kane - Vice President of Investor RelationsJason ...
Townsquare Media, Inc.'s outlook for 2026: digital & media partnerships drive growth as AI headwinds fade. Click for this TSQ ...
The FDA’s real-time clinical trial mechanism allows drug sponsors to transmit data immediately to the regulator through the ...
Big Tech's $725 Billion AI Spend Has A New Bottleneck. What Big Tech’s Capex Explosion Tells Us About AI’s Real Constraint ...
The Edmonds City Council approved the City’s Comprehensive Safety Action Plan, which highlights projects meant to reduce ...
Stockhead on MSN
Health Check: Syntara goes to the well for $10 million to fund advanced cancer trial
Myelofibrosis drug developer Syntara has gone to the well for $10m, the latest biotech to tap the market in a ... Read More ...
Detailed price information for Centerra Gold Inc. (CG-T) from The Globe and Mail including charting and trades.
AI technology may be new, but insurers often struggle when the operating model underneath it remains unchanged.
Today, we will talk about our first quarter 2026 performance, our main achievements, and our priorities for the future. After the presentation, we will be available for the Q&A session, where our team ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results